Teva enjoyed $3.3B in Israeli tax breaks; India's Cipla wraps Cipla Medpro buyout; Merck KGaA eyes collaborations in Korea;

 @FiercePharma: China's corruption watchdogs eye 4 more drugmakers as GSK manager confesses to bribery on TV. More | Follow @FiercePharma

@CarlyHFierce: NICE says no to Pfizer's Bosulif. Been pretty skeptical about new cancer drugs. Release | Follow @CarlyHFierce

> Teva Pharmaceutical ($TEVA) reaped nearly 12 billion shekels ($3.3 billion) in tax breaks between 2006 and 2011, the Israeli government's Tax Authority says. Report

> India's Cipla wrapped up its buyout of South African affiliate Cipla Medpro for 4.51 billion rand, or about $457 million. Report

> Merck KGaA's new CEO in Korea says he's looking for "seamless collaboration" with local biotech companies. Report

> Pharma machinery makers in China want the government to impose a dumping duty on imports, saying a lack of restrictions is hurting domestic companies. Report

> The FDA approved the first brain wave test to identify children with attention deficit hyperactivity disorder. Report

> The decline in cholesterol levels in the U.S. has leveled off, triggering worries about gains in cardiovascular health. Report

Medical Device News

 @FierceMedDev: Boston Scientific, Sorin team up on heart valve. Article | Follow @FierceMedDev

 @MarkHFierce: The FDA approved the first Dx test designed to help diagnose ADHD in children and teens. EEG tech is a core element. Press release | Follow @MarkHFierce

 @DamianFierce: No Synthes, no growth for JNJ's medical devices and diagnostics business. Report | Follow @DamianFierce

> Myriad ups patient assistance as it sues cheaper rivals. Story

> NEA invests $4.3M in Cartiva's joint replacement work. Item

Biotech News

 @FierceBiotech: ICYMI: Merck's positive Alzheimer's study spotlights BACE race. Article | Follow @FierceBiotech

 @JohnCFierce: In pharma, incremental innovation lives on. Story | Follow @JohnCFierce

 @RyanMFierce: A $30.6M financing for Ayasdi, BigData analytics and discovery for life sciences, energy and other industries. Release | Follow @RyanMFierce

> $350M batch of biotech IPOs to test investors' appetite for risk. Story

> Rumors of big Roche bid for Alexion cool as analysts weigh in. News

Biotech Research News

 @EmilyMFierce: Obesity gene found to regulate hunger hormone. More | Follow @EmilyMFierce

> Researchers unveil largest database of cancer-related genetic variations. News

> Senate committee approves funding increase for NIH in FY 2014. Article

> Sorrento Therapeutics, Israeli university team up to fight hep C. Item

Pharma Manufacturing News

 @EricPFierce: BTG said its Biocompatibles unit had received an FDA warning letter for its plant in Oxford, CT. Article | Follow @EricPFierce

> FDA lays out when plant inspection delays will lead to penalties. Report

> Roche to put $105M into training center. News

> Sanofi starts production on complex dengue vaccine. Article

And Finally... Scientists have discovered how the "obesity gene" increases hunger. Report

Suggested Articles

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.

During David Loew's tenure, Sanofi Pasteur bought Protein Sciences, whose recombinant technology is being applied to a COVID-19 vaccine.